Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer

Cytogenetics and Cell Genetics

Volumn 86, Issue 2, 1999, Pages 136-139

  Vasen, Hans F A ^a   Wijnen, J ^b  

^a Netherlands Found Detection H   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; CANCER RISK; CLINICAL GENETICS; COLORECTAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; ONSET AGE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032854409     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015366     Document Type: Short Survey

References (24)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 21:1481-1487 (1998).
2. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM: Mutation in the DNA mismatch repair gene homologue MLH1 is associated with hereditary non-polyposis colorectal cancer. Nature 368:258-261 (1994).
3. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Bum J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum molec Genet 6:105-110 (1997).
4. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell 75:1027-1038 (1993).
5. Jager AC, Bisgaard ML, Myrhoj T, Bernstein I, Rehfeld JF, Nielsen FC: Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic MLH1 expression. Am J hum Genet 61:129-138 (1997).
6. Järvinen HJ, Mecklin J-P, Sistonen P: Screening reduces colorectal cancer rate in hereditary nonpolyposis colorectal cancer (HNPCC) families. Gastroenterology 108:1405-1411 (1995).
7. Jass JR, Pokos V, Arnold JL, Cottier DS, Jeevaratnam P, Van de Water NS, Browett PJ, Winship IM, Lane MR: Colorectal neoplasm detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability. J molec Med 74:547-551 (1996).
8. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17:79-83 (1997).
9. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Metzler PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B: Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215-1225 (1993).
10. Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y: HNPCC associated with germline mutation in the TGF-β type II receptor gene. Nature Genet 19:17-18 (1998).
11. Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 78:1149-1167 (1996).
12. Mecklin J-P, Järvinen HJ, Aukee S, Elomaa I, Karjalainen K: Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol 22:449-453 (1987).
13. Mecklin J-P, Svendsen LB, Peltomaki P, Vasen HFA: Hereditary nonpolyposis colorectal cancer. Scan J Gastroenterol 29:673-677 (1994).
14. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80 (1994).
15. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD: Mutation of a MutL homolog in hereditary colon cancer. Science 263:1625-1629 (1994).
16. Peltomaki P, Vasen HFA, and the ICG-HNPCC: Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 113:1146-1158 (1997).
17. Vasen HFA, van Ballegooijen M, Buskens E, Kleibeuker JK, Taat BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P: A cost-effectiveness analysis of colorectal screening of hereditary non-polyposis colorectal carcinoma gene carriers. Cancer 82:1632-1637 (1998).
18. Vasen HFA, den Hartog-Jager FCA, Menko FH, Nagengast FM: Screening for hereditary non-polyposis colorectal cancer: a study of twenty-two kindreds in the Netherlands. Am J Med 86:278-281 (1989).
19. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rect 34:224-225 (1991).
20. Vasen HFA, Taal BG, Griffioen G, Nagengast FM, Cats A, Menko FH, Oskam W, Kleibeuker JH, Offerhaus GJA, Meera Khan P: Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut 35:1262-1266 (1994).
21. Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard M-L, Mohr J, Fodde R, Khan PM: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027 (1996); erratum: Gastroenterology 111:1402 (1996).
22. Watson P, Vasen HFA, Mecklin JP, Lynch HT: The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 96:516-20 (1994).
23. Weber T: Clinical surveillance recommendations adopted for HNPCC. Lancet 348:465 (1996).
24. Wijnen JT, Vasen HFA, Meera Khan P, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P, Fodde R: Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339:511-518 (1998).